Ma, Feiyang http://orcid.org/0000-0002-6260-0787
Hughes, Travis K.
Teles, Rosane M. B. http://orcid.org/0000-0003-2908-3244
Andrade, Priscila R.
de Andrade Silva, Bruno J.
Plazyo, Olesya
Tsoi, Lam C.
Do, Tran
Wadsworth, Marc H. II
Oulee, Aislyn http://orcid.org/0000-0003-1300-9840
Ochoa, Maria Teresa
Sarno, Euzenir N.
Iruela-Arispe, M. Luisa http://orcid.org/0000-0002-3050-4168
Klechevsky, Eynav http://orcid.org/0000-0001-6121-1571
Bryson, Bryan
Shalek, Alex K. http://orcid.org/0000-0001-5670-8778
Bloom, Barry R.
Gudjonsson, Johann E. http://orcid.org/0000-0002-0080-0812
Pellegrini, Matteo
Modlin, Robert L. http://orcid.org/0000-0003-4720-031X
Article History
Received: 25 December 2020
Accepted: 11 May 2021
First Online: 24 June 2021
Competing interests
: A.K.S. reports compensation for consulting and/or scientific advisory board membership from Merck, Honeycomb Biotechnologies, Cellarity, Cogen Therapeutics, Orche Bio and Dahlia Biosciences. The other authors declare no competing interests.